[HTML][HTML] Data-driven translational prostate cancer research: from biomarker discovery to clinical decision

Y Lin, X Zhao, Z Miao, Z Ling, X Wei, J Pu… - Journal of Translational …, 2020 - Springer
Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high
heterogeneity among males worldwide. In the era of big data and artificial intelligence, the …

Data-driven translational prostate cancer research: from biomarker discovery to clinical decision

Y Lin, X Zhao, Z Miao, Z Ling, X Wei… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high
heterogeneity among males worldwide. In the era of big data and artificial intelligence, the …

Data-driven translational prostate cancer research: from biomarker discovery to clinical decision

Y Lin, X Zhao, Z Miao, Z Ling, X Wei, J Pu… - Journal of …, 2020 - go.gale.com
Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high
heterogeneity among males worldwide. In the era of big data and artificial intelligence, the …

Data-driven translational prostate cancer research: from biomarker discovery to clinical decision

Y Lin, X Zhao, Z Miao, Z Ling, X Wei… - Journal of …, 2020 - search.proquest.com
Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high
heterogeneity among males worldwide. In the era of big data and artificial intelligence, the …

[引用][C] Data-driven translational prostate cancer research: from biomarker discovery to clinical decision

Y Lin, X Zhao, Z Miao, Z Ling, X Wei, J Pu… - Journal of …, 2020 - jglobal.jst.go.jp
Cancer; Impact of age at diagnosis of de novo metastatic prostate cancer on survival; B
Bernard, C Burnett, CJ Sweeney, JR Rider, SS Sridhar; 2019; 10.1002/cncr. 32630; …

Data-driven translational prostate cancer research: from biomarker discovery to clinical decision

Y Lin, X Zhao, Z Miao, Z Ling, X Wei, J Pu… - Journal of …, 2020 - hero.epa.gov
Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high
heterogeneity among males worldwide. In the era of big data and artificial intelligence, the …

[HTML][HTML] Data-driven translational prostate cancer research: from biomarker discovery to clinical decision

Y Lin, X Zhao, Z Miao, Z Ling… - Journal of …, 2020 - … -medicine.biomedcentral.com
Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high
heterogeneity among males worldwide. In the era of big data and artificial intelligence, the …

[HTML][HTML] Data-driven translational prostate cancer research: from biomarker discovery to clinical decision

Y Lin, X Zhao, Z Miao, Z Ling, X Wei, J Pu… - Journal of …, 2020 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high
heterogeneity among males worldwide. In the era of big data and artificial intelligence, the …

[PDF][PDF] Data-driven translational prostate cancer research: from biomarker discovery to clinical decision

Y Lin, X Zhao, Z Miao, Z Ling, X Wei, J Pu, J Hou… - 2020 - scholar.archive.org
Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high
heterogeneity among males worldwide. In the era of big data and artificial intelligence, the …

Data-driven translational prostate cancer research: from biomarker discovery to clinical decision.

Y Lin, X Zhao, Z Miao, Z Ling, X Wei, J Pu… - Journal of …, 2020 - europepmc.org
Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high
heterogeneity among males worldwide. In the era of big data and artificial intelligence, the …